The Numbers Dont Lie A 2025 systematic review published in HSS Journal did what science is supposed to do: they screened the entire published literature on BPC-157 from an orthopaedic sports medicine perspective
Simultaneously, the peptide inhibits enzymes involved in lipogenesis, reducing the conversion of excess calories into stored fat
TB500 often paired with BPC157 for regenerative and anti-inflammatory effects
Moreover, it is in the public interest to waive the 60-day delay of the effective date, so that providers, and suppliers are adequately reimbursed starting at the beginning of the calendar year
Human trials are still limited, so we use them carefully and with full informed consent
As a result, BPC-157 is not FDA-approved for the treatment of joint or tendon injuries, and its use remains experimental or off-label